INT J PSYCHIAT CLIN - International Journal of Psychiatry in Clinical Practice

Publications

  1. 2020
  2. The rates of co-occurring behavioural addictions in treatment-seeking individuals with obsessive-compulsive disorder: A preliminary report

    Brakoulias, V., Starcevic, V., Albert, U., Arumugham, S. S., Bailey, B. E., Belloch, A., Borda, T., Dell'Osso, L., Elias, J. A., Falkenstein, M. J., Ferrao, Y. A., Fontenelle, L. F., Jelinek, L., Kay, B., Lochner, C., Maina, G., Marazziti, D., Matsunaga, H., Miguel, E. C., Morgado, P., Pasquini, M., Perez-Rivera, R., Potluri, S., Reddy, J. Y. C., Riemann, B. C., do Rosario, M. C., Shavitt, R. G., Stein, D. J., Viswasam, K. & Fineberg, N. A., 2020, In: INT J PSYCHIAT CLIN. 24, 2, p. 173-175

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  3. 2016
  4. Evaluation of self-care skills training and solution-focused counselling for health professionals in psychiatric medicine: a pilot study

    Mache, S., Baresi, L., Bernburg, M. & Groneberg, D. A., 11.2016, In: INT J PSYCHIAT CLIN. 20, 4, p. 239-44 6 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  5. 2008
  6. Treatment of depressive symptoms and attitudes towards treatment options in a representative German general population sample

    Berner, M. M., Kriston, L., Sitta, P. & Härter, M., 2008, In: INT J PSYCHIAT CLIN. 12, 1, p. 5-10 6 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  7. 2006
  8. Clinical effectiveness of quetiapine: findings of a post-Marketing surveillance study in patients with schizophrenia.

    Lambert, M., Reimitz, P. E. & Naber, D., 2006, In: INT J PSYCHIAT CLIN. 10, p. 204-212

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  9. Effectiveness, tolerability and subjective well-being in patients receiving quetiapine: findings of a post-marketing surveillance study in schizophrenia

    Lambert, M., Reimitz, P-E. & Naber, D., 2006, In: INT J PSYCHIAT CLIN. 10, 3, p. 204-12 9 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  10. 2005
  11. Correlates of subjective well-being in schizophrenic patients treated with atypical antipsychotics.

    Schimmelmann, B. G., Moritz, S., Karow, A., Schafer, I., Bussopulos, A., Golks, D., Krausz, M., Naber, D. & Lambert, M., 2005, In: INT J PSYCHIAT CLIN. 9, p. 94-98

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  12. Olanzapine in patients with a first-episode psychosis non-responsive, intolerant or non-compliant to a first-line trial of risperidone.

    Lambert, M., Conus, P., Schimmelmann, B., Naber, D. & McGorry, P. D., 2005, In: INT J PSYCHIAT CLIN. 9, p. 244-250

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  13. Olanzapine in subjects with a first-episode psychosis non-responsive, intolerant or non-compliant to a first-line trial of risperidone

    Lambert, M., Conus, P., Naber, D., Mcgorry, P. D. & Schimmelmann, B. G., 2005, In: INT J PSYCHIAT CLIN. 9, 4, p. 244-50 7 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  14. 2003
  15. Amisulpride: a safe and effective option for the long-term treatment of patients with schizophrenia.

    Naber, D. & Lambert, M., 2003, In: INT J PSYCHIAT CLIN. 7, p. 167-175

    Research output: SCORING: Contribution to journalSCORING: Review articleResearch

  16. 1999
  17. Sertindole decreases hospitalisation and improves the quality of life of schizophrenic patients.

    Naber, D. & Lambert, M., 1999, In: INT J PSYCHIAT CLIN. 2, p. 73-77

    Research output: SCORING: Contribution to journalSCORING: Review articleResearch